Explore the Agenda
8:00 am Registration & Coffee
8:50 am Chair’s Opening Remarks
Measuring the True Impact of Patient Engagement Across the Entire Product Lifecycle
9:00 am Measurement from the Chief Patient Officer’s Perspective: Creating Organisational Frameworks that Combine Business Objectives with Unmet Patient Needs
- Building end-to-end patient engagement strategies that integrate business priorities with unmet patient needs
- Measuring dual impact by tracking both business-value and patient-value outcomes
- Demonstrating results effectively to internal leadership, regulators, and external stakeholders
9:30 am How to Define the Impact of Patient Engagement in Early Research: A Target Value Profile Approach
- Defining patient‑driven Target Value Profiles (TVPs) to set prospective expectations for value in early and preclinical research
- Applying qualitative and quantitative insights from patient advisory panels to inform early research decision‑making
- Translating Target Product Profile (TPP) characteristics to value attributes and impact areas under Target Value Profile (TVP)
- Embedding patient‑defined value criteria into forward‑looking KPIs to strengthen long‑term R&D outcomes
10:00 am From Corporate Purpose to Patient Impact: A Company‑Wide Framework for Patient Engagement
- Designing a systematic, company‑wide patient engagement framework to embed the patient voice across R&D, access and commercialization
- Moving from activity‑based engagement to value‑ and impact‑driven patient involvement across the asset lifecycle
- Linking patient engagement outcomes to corporate purpose, culture and ESG commitments, beyond individual initiatives
- Measuring the impact of patient engagement at different stages of the asset lifecycle, from clinical development to market access and support programmes
10:30 am Morning Break & Speed Networking
Join our speed networking session tailored for Patient Engagement professionals, like yourselves, to connect with fellow industry peers to facilitate rapid yet meaningful exchanges of insights and expertise. Elevate your networking experience during this session designed for impactful connections within the space
11:30 am From Insight to Impact: Integrating Feasibility With Patient & Site Engagement to Measure What Truly Drives Trial Success
- Feasibility as the earliest measure of engagement impact
- Moving from activity metric to outcome driven KPIs
- Creating a shared measurement framework across functions
12:00 pm From Reporting to Real Impact: Measuring Patient Engagement in the Evolving ESG Landscape
- An overview of the latest CSRD changes and how they open the door to stronger, more structured PE reporting
- Insight into how other global ESG frameworks – including the UN Sustainable Development Goals (SDGs), Social Return on Investment (SROI), and others – are being leveraged to assess and report on engagement with patients and communities
- A first look at PFMD’s third annual ESG landscaping analysis, offering real-world examples and trends across the industry
12:30 pm Call to Action: Measuring What Matters Most to Patients in Eastern Europe
- Evaluating patient input impact on payer readiness and health technology assessment strategies
- Tracking measurable outcomes from patient engagement influencing launch planning and payer messaging
- Addressing challenges in differentiating objective patient insights from anecdotal feedback
1:00 pm Lunch & Networking
2:00 pm Developing & Strengthening Patient Partnerships: Demonstrating the Impact of Lived-Experience Insights Across the Access to Medicine Domains
- Measuring short, medium, and long-term patient engagement activities supporting market access
- Developing KPIs and frameworks to evaluate patient partnership outputs
- Reflecting on lessons learned, data and terminology limitations and refining how we advocate for ‘permission’ to invest and engage
Embedding Patient Engagement into Strategy: Frameworks to Prove Value Across Teams
2:30 pm Proving the Intangible by Translating Qualitative Patient Insights into Business Metrics
- Combining qualitative and quantitative data to create credible evidence of patient engagement impact
- Validating and calibrating patient-reported insights using robust methods to ensure leadership confidence
- Framing complex qualitative data into actionable business language that drives strategic decisions
3:00 pm Network & Learn Break: Measurement in Practice
This interactive break is your opportunity to explore how teams are approaching patient engagement measurement in practice. Discover real-world examples, frameworks, and work in progress, and engage directly with peers to exchange ideas and experiences. Use this time to discuss how others are defining KPIs, capturing impact, and building credible evidence across the lifecycle.
If you’d like to share an approach, framework, or piece of work, please contact info@hansonwade.com
3:45 pm Roundtable: Advancing Pre-Competitive Collaboration to Standardise Patient Engagement Metrics
- Driving industry-wide consensus on patient engagement benchmarks to enhance credibility and comparability
- Overcoming data-sharing, IP, and trust barriers to unlock collaborative learning and innovation
- Leveraging insights from leading consortia to adopt proven measurement standards and accelerate sector progress
4:15 pm From Insight to Impact: Harnessing the Patient Centricity Model for Engagement Value
- Novo Nordisk’s journey balancing system-led patient-experience to consumer-led patient experience data and evidence
- Integrating patient and consumer centricity into project strategies, evidence planning and advocacy
- Sharing case studies highlighting successes and challenges in capturing patient insights and translating them into actionable strategies
- Discussing best practices and collaborative approaches to scale patient engagement initiatives across different functions, driving organisational alignment and enhanced patient outcomes